Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomabu Adjobimey

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|April 11, 2022
Distinct N-Linked Immunoglobulin G Glycosylation Patterns Are Associated With Chronic Pathology and Asymptomatic Infections in Human Lymphatic FilariasisTomabu Adjobimey, Achim Hoerauf
Parasitology Research|September 6, 2019
IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a Fc-Fc-dependent mechanismUlrich F Prodjinotho, Achim Hoerauf, Tomabu Adjobimey
BMC Medicine|June 28, 2022
Helminth antigens differentially modulate the activation of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes of convalescent COVID-19 patients in vitroTomabu Adjobimey, Julia Meyer, Vedrana Terkeš, et al.
Innate Immunity|March 27, 2013
Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-culturesTomabu Adjobimey, Judith Satoguina, Johannes Oldenburg, et al.
European Journal of Immunology|October 17, 2008
Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-betaJudith S Satoguina, Tomabu Adjobimey, Kathrin Arndts, et al.
Frontiers in Immunology|July 8, 2022
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 VaccinesTomabu Adjobimey, Julia Meyer, Leander Sollberg, et al.
Plos Neglected Tropical Diseases|July 26, 2017
Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytesUlrich F Prodjinotho, Charlotte von Horn, Alex Y Debrah, et al.
Journal of Ethnopharmacology|March 12, 2004
Evaluation of ethnobotanically selected Benin medicinal plants for their in vitro antiplasmodial activityBernard Weniger, Latifou Lagnika, Catherine Vonthron-Sénécheau, et al.
Frontiers in Immunology|August 25, 2023
Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in BeninTomabu Adjobimey, Julia Meyer, Anneka Hennenfent, et al.
Frontiers in Immunology|January 19, 2026
Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinationsJulia Meyer, Achim Hoerauf, Aleksandra Elzbieta Dubiel, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|April 11, 2022
Distinct N-Linked Immunoglobulin G Glycosylation Patterns Are Associated With Chronic Pathology and Asymptomatic Infections in Human Lymphatic FilariasisTomabu Adjobimey, Achim Hoerauf
Parasitology Research|September 6, 2019
IgG4 antibodies from patients with asymptomatic bancroftian filariasis inhibit the binding of IgG1 and IgG2 to C1q in a Fc-Fc-dependent mechanismUlrich F Prodjinotho, Achim Hoerauf, Tomabu Adjobimey
BMC Medicine|June 28, 2022
Helminth antigens differentially modulate the activation of CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes of convalescent COVID-19 patients in vitroTomabu Adjobimey, Julia Meyer, Vedrana Terkeš, et al.
Innate Immunity|March 27, 2013
Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-culturesTomabu Adjobimey, Judith Satoguina, Johannes Oldenburg, et al.
European Journal of Immunology|October 17, 2008
Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-betaJudith S Satoguina, Tomabu Adjobimey, Kathrin Arndts, et al.
Frontiers in Immunology|July 8, 2022
Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 VaccinesTomabu Adjobimey, Julia Meyer, Leander Sollberg, et al.
Plos Neglected Tropical Diseases|July 26, 2017
Pathological manifestations in lymphatic filariasis correlate with lack of inhibitory properties of IgG4 antibodies on IgE-activated granulocytesUlrich F Prodjinotho, Charlotte von Horn, Alex Y Debrah, et al.
Journal of Ethnopharmacology|March 12, 2004
Evaluation of ethnobotanically selected Benin medicinal plants for their in vitro antiplasmodial activityBernard Weniger, Latifou Lagnika, Catherine Vonthron-Sénécheau, et al.
Frontiers in Immunology|August 25, 2023
Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in BeninTomabu Adjobimey, Julia Meyer, Anneka Hennenfent, et al.
Frontiers in Immunology|January 19, 2026
Temporal dynamics of SARS-CoV-2 antibodies and IgG subclasses following multiple doses and diverse COVID-19 vaccine combinationsJulia Meyer, Achim Hoerauf, Aleksandra Elzbieta Dubiel, et al.
Pageof 3